Clifton Mining Company - ASAP Close to Hospital Approval
ALPINE, UTAH, Nov. 11 /PRNewswire-FirstCall/ - Clifton Mining Company (OTC: CFTN ) is pleased to announce that American Biotech Labs, a company in which Clifton owns approximately 30% has finished the approval process with the U.S. EPA and expects to get full hospital approval in the next few weeks.
The Testing
In the test work for the EPA hospital approval, the ASAP Solution(R) had to kill hundreds of thousands of some of the deadliest types of bacteria found in the United States within minutes, and it proved able to do so. There were approximately 1600 individual bacterial tests in just one series alone. American Biotech's product was able to pass all the tests.
The Hospital Approval
American Biotech Labs expects to get the full hospital disinfectant approval within the next 15-45 days. The approval will open the door to sell the highly effective, yet non-toxic disinfectant to thousands of hospitals, clinics, rest homes, and other healthcare facilities world wide. Management expects sales of the new disinfectant to possibly begin as soon as January 2003. Said Keith Moeller, V.P., "This will be a very important product for the market. Because this product is non-toxic and yet highly effective at killing even the MRSA super bacteria, we expect sales to boom world wide. Unlike other disinfectants, this product can be used in and around patients to kill bacteria with no adverse effect. It is so safe that it could be sprayed right on the skin or even consumed orally with no adverse consequences."
Malaria Testing/Drug Approval
A new human trial specifically testing ASAP's effectiveness on malaria is under way in Ghana, West Africa. In the first two tests, 19 people who had been diagnosed with malaria were treated with the ASAP Solution. All 19 people (mostly children) were reported by the doctors as being fully recovered within just seven days. The latest malaria tests should be completed within the next 60 days.
With no reported failures, the human tests have gone so well that the official Food and Drug Board of Ghana has already approved the ASAP Solution(R) for drug registration. Recent West African trials also tested the product as a treatment for fungal skin infections, vaginal infections, urinary tract infections, tonsilitis, pharingitis, some sexually transmitted diseases, conjunctivitis, upper respiratory tract infections, nasal and sinus problems, etc. In almost every human case tested so far, full recovery was reached in just 1-7 days.
Clifton trades on the U.S. OTC: (CFTN).
Note: Any statements released by Clifton Mining Company that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that forward looking statements invoke risk and uncertainties that may affect the company's business prospects and performance. These include economic, competitive, governmental, technological and other factors discussed in the company's business plan and due-diligence information.
SOURCE Clifton Mining Company
CO: Clifton Mining Company
ST: Utah
SU:
prnewswire.com
11/11/2002 07:00 EST |
